TABLE 3.
Antifungal agent | MIC obtained by indicated method for:
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Candida parapsilosis ATCC 22019
|
Candida krusei ATCC 6258
|
Cryptococcus neoformans ATCC 90112
|
Aspergillus flavus ATCC 204304
|
Aspergillus fumigatus ATCC 204305
|
||||||
EUCASTb method | CLSI procedure | EUCASTb method | CLSI procedure | Modifiedc method | CLSI procedure | Modifiedd method | CLSI procedure | Modifiedd method | CLSI procedure | |
Amphotericin B | 0.12 - 0.50 | 0.25 - 1.0 | 0.12 - 0.50 | 0.25 - 1.0 | 0.12 - 0.50 | 0.12 - 0.50 | 0.25 - 1.0 | 0.50 - 2.0 | 0.25 - 1.0 | 0.50 - 2.0 |
Flucytosine | 0.12 - 0.50 | 0.12 - 0.50 | 1.0 - 4.0 | 4.0 - 16.0 | 8.0 - 32.0 | 4.0 - 16.0 | ND | ND | ND | ND |
Fluconazole | 1.0 - 4.0 | 2.0 - 8.0 | 8.0 - 32.0 | 16.0 - 64.0 | 8.0 - 32.0 | 8.0 - 32.0 | ND | ND | ND | ND |
Itraconazole | 0.03 - 0.12 | 0.06 - 0.25 | 0.06 - 0.25 | 0.12 - 0.50 | 0.25 - 1.0 | 0.25 - 1.0 | 0.12 - 0.50 | 0.12 - 0.50 | 0.12 - 1.0 | 0.25 - 1.0 |
Voriconazole | 0.03 - 0.12 | 0.015 - 0.12 | 0.06 - 0.25 | 0.06 - 0.50 | 0.25 - 1.0 | 0.25 - 1.0 | 0.50 - 2.0 | 0.50 - 1.0 | 0.25 - 1.0 | 0.25 - 1.0 |
Caspofungin | 0.50 - 2.0 | 0.50 - 4.0 | 0.12 - 0.50 | 0.25 - 1.0 | >16.0 | >16.0 | 4.0 - 16.0 | 4.0 - 16.0 | 0.12 - 0.50 | 0.12 - 0.50 |
Posaconazole | 0.015 - 0.06 | 0.03 - 0.12 | 0.03 - 0.12 | 0.06 - 0.50 | 0.12 - 0.50 | 0.25 - 1.0 | 0.12 - 0.25 | 0.12 - 0.25 | 0.06 - 0.25 | 0.12 - 0.50 |